Neurosurgical treatment of brain tumors in children

Pediatric Clinics of North America

Volumn 51, Issue 2, 2004, Pages 327-357

  Maher, Cormac O ^a   Raffel, Corey ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ASTROCYTOMA; BRAIN TUMOR; CANCER CHEMOTHERAPY; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CRANIOPHARYNGIOMA; EPENDYMOMA; GERM CELL TUMOR; GLIOMA; GROWTH RETARDATION; HUMAN; LEUKOENCEPHALOPATHY; MEDULLOBLASTOMA; NEUROIMAGING; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR CRANIAL FOSSA TUMOR; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME;

EID: 1842557841     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0031-3955(03)00206-2     Document Type: Review

References (228)

1. Gold E. Epidemiology of brain tumors. Rev Cancer Epidemiol 1982;1:245.
2. Ries LA, Kosary CL, Hankey BF, et al, editors. SEER Cancer Statistics Review, 1973-1994. Bethesda: National Institutes of Health, National Cancer Institute; 1997 [NIH Publication # 97-2789].
3. Mehta V, Chapman A, McNeely PD, et al. Latency between symptom onset and diagnosis of pediatric brain tumors: an Eastern Canadian geographic study. Neurosurgery 2002;51(2):365-73.
4. Mueller B, Gurney JG. Epidemiology of pediatric brain tumors. Neurosurg Clin N Am 1992;3:715-21.
5. Albright A, Wisoff JH, Zeltzer PM, et al. Current neurosurgical treatment of medulloblastomas in children. Pediatr Neurosci 1989;15(6):276-82.
6. Albright AL. Posterior fossa tumors. Neurosurg Clin N Am 1992;3:881-91.
7. Healey E, Barnes PD, Kupsky WJ, et al. The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery 1991;28:666-71.
8. Park T, Hoffman HJ, Hendrick EB, et al. Medulloblastoma: clinical presentation and management. J Neurosurg 1983;58:543-52.
9. Al-Mefty O, Jinkins JR, El-Senoussi M, et al. Medulloblastomas: a review of modern management with a report on 75 cases. Surg Neurol 1985;24:606-24.
10. Chatty E, Earler KM. Medulloblastoma: a report of 201 cases with emphasis on the relationship of histologic variants to survival. Cancer 1971;28:977.
11. Farwell J, Dohrman GJ, Flannery JT. Medulloblastoma in childhood: an epidemiological study. J Neurosurg 1984;61:657-64.
12. Hershatter B, Halpern EC, Cox EB. Medulloblastoma: the Duke University Medical Center experience. Int J Radiat Oncol Biol Phys 1986;12:1771.
13. Evans DG, Farndon PA, Burnell LD, et al. The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer 1991;64(5):959-61.
14. Evans DGR, Ladusaris EJ, Rimmer S, et al. Complications of the naevoid basal cell carcinoma syndrome: results of a population based study. J Med Genet 1993;30:460-4.
15. Kimonis VE, Goldstein AM, Pastakia B, et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet 1997;69:299-308.
16. Paraf F, Jothy S, van Meir EG. Brain-tumor-polyposis syndrome: two genetic diseases? J Clin Oncol 1997;15:2744-58.
17. Hart M, Earle KM. Primitive neuroectodermal tumors of the brain in children. Cancer 1973;32:890-7.
18. Rorke LB. The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. J Neuropathol Exp Neurol 1983;42:1-15.
19. Barkovich AJ. Neuroimaging of pediatric brain tumors. Neurosurg Clin N Am 1992;3(4):739-69.
20. Lee M, Wisoff JH, Abbott R, et al. Management of hydrocephalus in children with medulloblastoma: prognostic factors for shunting. Pediatr Neurosurg 1994;20:240-7.
21. Sandhu A, Kendall B. Computed tomography in management of medulloblastomas. Neuroradiology 1987;29:444-52.
22. Zee C, Segall HD, Nelson M, et al. Infratentorial tumors in children. Neuroimag Clin North Am 1993;3:705-14.
23. Blaser S, Harwood-Nash DCF. Neuroradiology of pediatric posterior fossa medulloblastomas. J Neurooncol 1996;29:23-34.
24. Chang CH, Housepian EM, Herbert C. An operative staging system and a megavoltage radiotherapeutic technique for cerebellar medulloblastoma. Radiology 1969;93:1351-9.
25. Albright AL. The value of precraniotomy shunts in children with posterior fossa tumors. Clin Neurosurg 1983;30:278-85.
26. David K, Casey ATH, Hayward RD, et al. Medulloblastoma: is the 5-year survival rate improving? J Neurosurg 1997;86:13-21.
27. Goel A. Whither preoperative shunts for posterior fossa tumors? Br J Neurosurg 1993;7:395-9.
28. Bourne J, Geyer R, Berger M, et al. The prognostic significance of postoperative residual contrast enhancement on CT scan in pediatric patients with medulloblastoma. J Neurooncol 1992;14:263-70.
29. Bloom J, Wallace ENK, Henk JM. The treatment and prognosis of medulloblastoma in children: a study of 82 verified cases. AJR Am J Roentgeonol 1969;105:43-62.
30. Cervoni L, Cantore G. Medulloblastoma in pediatric age: a single-institution review of prognostic factors. Childs Nerv Syst 1995;11:80-5.
31. Choux M, Lena G, Hassoun J. Prognosis and long-term follow-up in patients with medulloblastoma. Clin Neurosurg 1982;30:246-77.
32. Duffner P, Cohen ME, Myers MH, et al. Survival of children with brain tumors: SEER program 1973-1980. Neurology 1986;36:597-601.
33. Mazzola CA, Pollack IF. Medulloblastoma. Curr Treat Options Neurol 2003;5(3):189-98.
34. Hoffman H, Hendrick EB, Humphreys RP. Management of medulloblastoma in childhood. Clin Neurosurg 1982;30:226-45.
35. Jenkin D, Goddard K, Armstrong D, et al. Posterior fossa medulloblastoma in childhood: treatment results and a proposal for a new staging system. Int J Radiat Oncol Biol Phys 1990;19:265-74.
36. Norris D, Bruce DA, Byrd RL, et al. Improved relapse-free survival in medulloblastoma utilizing modern techniques. Neurosurgery 1981;9:661-4.
37. Packer R, Sutton LN, D'Angio G, et al. Management of children with primitive neuroectodermal tumors of the posterior fossa/medulloblastoma. Pediatr Neurosci 1986;12:272-82.
38. Albright A, Wisoff JH, Zeltzer PM, et al. Effects of medulloblastoma resections on outcomes in children: a report from the Children's Cancer Group. Neurosurgery 1996;38:265-70.
39. Erashin Y, Mutluer S, Cagli S, et al. Cerebellar mutism: report of seven cases and review of the literature. Neurosurgery 1996;38:60-5.
40. Hirsch J, Renier D, Czernichow P, et al. Medulloblastoma in childhood. Survival and functional results. Acta Neurochir 1979;48:1-15.
41. Wisoff J, Epstein FJ. Pseudobulbar palsy after posterior fossa operation in children. Neurosurgery 1984;15(5):707-9.
42. Elster A, Arthur D. Cranial postoperative site: assessment with contrast-enhanced MR imaging. Radiology 1990;174:93-8.
43. Berger M, Baumeister B, Geyer JR, et al. The risks of metastases from shunting in children with primary central nervous system tumors. J Neurosurg 1991;74:872-7.
44. Hubbard J, Scheithauer BW, Kispert DB, et al. Adult cerebellar medulloblastomas: the pathological, radiographic, and clinical disease spectrum. J Neurosurg 1989;70:536-44.
45. Bouffett E, Bernard JL, Frappaz D, et al. M4 protocol for cerebellar medulloblastoma: supratentorial radiotherapy may not be avoided. Int J Radiat Oncol Biol Phys 1992;24:79-85.
46. Hughes E, Shillito J, Sallan SE, et al. Medulloblastoma at the Joint Center for Radiation Therapy between 1968 and 1984: the influence of radiation dose on the patterns of failure and survival. Cancer 1988;61:1992-8.
47. Patrice S, Tarbell NJ, Goumnerova LC, et al. Results of radiosurgery in the management of recurrent and residual medulloblastoma. Pediatr Neurosurg 1995;22:197-203.
48. Johnson D, McCabe MA, Nicholson HS, et al. Quality of long-term survival in young children with medulloblastoma. J Neurosurg 1994;80:1004-10.
49. Raimondi A, Tomita T. Medulloblastoma in childhood: comparative results of partial and total resection. Childs Brain 1979;5:310-28.
50. Evans A, Jenkin RDT, Sposto R, et al. The treatment of medulloblastoma: the results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. J Neurosurg 1990;72:572-82.
51. Krischer J, Ragab AH, Kun L, et al. Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg 1991;74(6):905-9.
52. Packer R, Sutton LN, Elterman R, et al. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 1994;81:690-8.
53. Tait D, Thornton-Jones H, Bloom HJG, et al. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology. Eur J Cancer 1990;26:464-9.
54. Ater JL, Woo SY, van Eys J. Update on MOPP chemotherapy as primary therapy for infant brain tumors. Pediatr Neurosci 1988;14:153.
55. Duffner P, Horowitz M, Krisher J, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 1993;24:1725-31.
56. Gentet JBE, Doz F, Tron P, et al. Preirradiation chemotherapy including "eight drugs in one day" regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study. J Neurosurg 1995;82:608-14.
57. Torres C, Rebsamen S, Silber JH, et al. Surveillance scanning of children with medulloblastoma. N Engl J Med 1994;330:892-5.
58. Mendel E, Levy ML, Raffel C, et al. Surveillance imaging in children with primitive neuroectodermal tumors. Neurosurgery 1996;38:692-4.
59. Elterman R, Bruce DA. The continued surveillance for recurrent medulloblastoma: primitive neuroectodermal tumors. Pediatr Neurosurg 1993;19:322.
60. Finlay J, Garvin J, Allen J. High-dose chemotherapy with autologous marrow rescue in patients with recurrent medulloblastoma/ primitive neuroectodermal tumors. Proceedings of the American Society of Clinical Oncology 1994;13:176.
61. Kun L, DeSouze B, Tefft M. The value of surveillance testing in childhood brain tumors. Cancer 1985;56:1818-23.
62. Wara W, Le OT, Sneed PK, et al. Pattern of recurrence of medulloblastoma after low-dose craniospinal radiotherapy. Int J Radiat Oncol Biol Phys 1994;30:551-6.
63. Garton G, Schomberg PJ, Scheithauer BW, et al. Medulloblastoma - prognostic factors and outcome of treatment: review of the Mayo Clinic experience. Mayo Clin Proc 1990;65:1077-86.
64. Gilles F, Sobel EL, Tavare CJ, et al. Age-related changes in diagnoses, histological features, and survival in children with brain tumors: 1930-1979. Neurosurgery 1995;37:1056-67.
65. Packer R. Chemotherapy for medulloblastoma/ primitive neuroectodermal tumors of the posterior fossa. Ann Neurol 1990;28:823-8.
66. Zimmerman R, Bilaniuk LT, Bruno L. Computed tomography of cerebellar astrocytoma. Am J Roentgenol 1978;130:929-33.
67. Morreale V, Ebersold MJ, Quast LM, et al. Cerebellar astrocytoma: experience with 54 cases surgically treated at the Mayo Clinic, Rochester, Minnesota, from 1978 to 1990. J Neurosurg 1997;87:257-61.
68. Coakley K, Huston J, Scheithauer BW, et al. Pilocytic astrocytomas: well-demarcated magnetic resonance appearance despite frequent infiltration histologically. Mayo Clin Proc 1995;70(8):747-51.
69. Hayostek C, Shaw EG, Scheithauer B, et al. Astrocytomas of the cerebellum: a comparative clinicopathologic study of pilocytic and diffuse astrocytomas. Cancer 1993;72(3):865-9.
70. Giannini C, Scheithauer BW. Classification and grading of low-grade astrocytic tumors in children. Brain Pathol 1997;7:785-98.
71. Tomlinson F, Scheithauer BW, Hayostek CH, et al. The significance of atypia and histologic malignancy in pilocytic astrocytoma of the cerebellum: a clinicopathologic and flow cytometric study. J Child Neurol 1994;9:301-10.
72. Krieger M, Gonzalez-Gomez I, Levy ML, et al. Recurrence patterns and anaplastic change in a long-term study of pilocytic astrocytomas. Pediatr Neurosurg 1997;27:1-11.
73. Strong J, Hatten Jr HP, Brown MT, et al. Pilocytic astrocytoma: correlation between the initial imaging features and clinical aggressiveness. AJR Am J Roentgenol 1993;161(2):369-72.
74. Dirven C, Mooij JJ, Molenaar WM. Cerebellar pilocytic astrocytoma: a treatment protocol based upon analysis of 73 cases and a review of the literature. Childs Nerv Syst 1997;13:17-23.
75. Hojer C, Hildebrandt G, Lanfermann H, et al. Pilocytic astrocytomas of the posterior fossa. A follow-up study in 33 patients. Acta Neurochir 1994;129:131-9.
76. Campbell J, Pollack IF. Cerebellar astrocytomas in children. J Neurooncol 1996;28:223-31.
77. Ushio Y, Arita N, Yoshmine T, et al. Malignant recurrence of childhood cerebellar astrocytoma: case report. Neurosurgery 1987;21:251-5.
78. Wallner K, Gonzales MF, Edwards MF, et al. Treatment results of juvenile pilocytic astrocytoma. J Neurosurg 1988;69:171-6.
79. Grabb P, Lunsford LD, Albright AL, et al. Stereotactic radiosurgery for glial neoplasms of childhood. Neurosurgery 1996;38:696-701.
80. Loiseau H, Dartigues JF, Cohadon F. Low-grade astrocytomas: prognosis factors and elements of management. Surg Neurol 1995;44:224-7.
81. Mamelak A, Prados MD, Obana WG, et al. Treatment options and prognosis for multicentric juvenile pilocytic astrocytoma. J Neurosurg 1994;81:24-30.
82. McCowage G, Tien R, McLendon R, et al. Successful treatment of childhood pilocytic astrocytomas metastatic to the leptomeninges with high-dose cyclophosphamide. Med Pediatr Oncol 1996;27:32-9.
83. Abdollahzadeh M, Hoffman HJ, Blazer SI, et al. Benign cerebellar astrocytoma in childhood: experience at the Hospital for Sick Children, 1980-1992. Childs Nerv Syst 1994;10:380-3.
84. Sutton L, Cnaan A, Klatt L, et al. Postoperative imaging of children with cerebellar astrocytomas. J Neurosurg 1996;84:721-5.
85. Kayama T, Tominaga T, Yoshimoto T. Management of pilocytic astrocytoma. Neurosurg Rev 1996;19:217-20.
86. Sobel E, Gilles FH, Leviton A, et al. Survival of children with infratentorial neuroglial tumors: the Childhood Brain Tumor Consortium. Neurosurgery 1996;39:45-54.
87. Kramer E, Vezina LG, Packer RJ, et al. Staging and surveillance of children with central nervous system neoplasms: recommendations of the neurology and tumor imaging committees of the Children's Cancer Group. Pediatr Neurosurg 1994;20:254-63.
88. Pagni C, Giordana MT, Canavero S. Benign recurrence of a pilocytic cerebellar astrocytoma 36 years after radical removal: case report. Neurosurgery 1991;28:606-9.
89. Allen J, Siffert J, Hukin J. Clinical manifestations of childhood ependymoma: a multitude of syndromes. Pediatr Neurosurg 1998;28:49-55.
90. Lefton D, Pinto RS, Martin SW. MRI features of intracranial and spinal ependymomas. Pediatr Neurosurg 1998;28:97-105.
91. Rawlings CI, Giangaspero F, Burger PC, et al. Ependymomas: a clinicopathologic study. Surg Neurol 1988;29:271-81.
92. Pollack I, Gerszten P, Martinez J, et al. Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery 1995;37:655-67.
93. Lyons M, Kelly PJ. Posterior fossa ependymomas: report of 30 cases and review of the literature. Neurosurgery 1991;28:659-64.
94. Sala F, Talacchi A, Mazza C, et al. Prognostic factors in childhood intracranial ependymomas: the role of age and tumor location. Pediatr Neurosurg 1998;28:135-42.
95. Salazar O, Rubin P, Bassano D, et al. Irradiation in intracranial ependymomas. Cancer 1975;35:1563-73.
96. Evans A, Anderson J, Lefkowitz-Boudreaux I, et al. Adjuvant chemotherapy in childhood posterior fossa ependymoma: craniospinal irradiation with or without CCNU, vincristine, and prednisone: a Children's Cancer Group study. Med Pediatr Oncol 1996;27:8-14.
97. Foreman N, Love S, Gill SS, et al. Second-look surgery for incompletely resected fourth ventricle ependymomas: technical case report. Neurosurgery 1997;40:856-60.
98. Rousseau P, Habrand JL, Sarrazin D, et al. Treatment of intracranial ependymomas of children: review of a 15-year experience. J Radiat Oncol Biol Phys 1994;28:381-6.
99. Awaad Y, Allen J, Miller D, et al. Deferring adjuvant therapy for totally resected ependymoma. Pediatr Neurol 1996;14:216-9.
100. Hukin J, Epstein F, Lefton D, et al. Treatment of intracranial ependymoma by surgery alone. Pediatr Neurosurg 1998;29:40-5.
101. Goldwein J, Leahy JM, Packer RJ, et al. Intracranial ependymomas in children. Int J Radiat Oncol Biol Phys 1990;19:1497-502.
102. Merchant T, Haida T, Wang MH, et al. Anaplastic ependymoma: treatment of pediatric patients with or without craniospinal radiation therapy. J Neurosurg 1997;86:943-9.
103. Leibel SA, Sheline GE. Radiation therapy for neoplasms of the brain. J Neurosurg 1987;66(1):1-22.
104. Siffert JA, Allen JC. Chemotherapy in recurrent ependymoma. Pediatr Neurosurg 1998;28:314-9.
105. McLaughlin M, Marcus Jr RB, Buatti JM, et al. Ependymoma: results, prognostic factos, and treatment recommendations. Int J Radiat Oncol Biol Phys 1998;40:845-50.
106. Van Veelen-Vincent MC, Pierre-Kahn A, Kalifa C, et al. Ependymoma in childhood: prognostic factors, extent of surgery, and adjuvant therapy. J Neurosurg 2002;97:827-35.
107. Lefkowitz I, Evans A, Sposto R, et al. Adjuvant chemotherapy of childhood posterior fossa ependymoma: craniospinal radiation with or without CCNU, vincristine, and prednisone. Pediatr Neurosci 1988;14:149.
108. Ikezaki K, Matsushima T, Inoue T, et al. Correlation of microanatomical localization with postoperative survival in posterior fossa ependymomas. Neurosurgery 1993;32:38-44.
109. Nazar G, Hoffman HJ, Becker LE, et al. Infratentorial ependymomas in childhood: prognostic factors and treatment. J Neurosurg 1990;72:408-17.
110. Robertson P, Zeltzer PM, Boyett JM, et al. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J Neurosurg 1998;88:695-703.
111. Ross G, Rubinstein LJ. Lack of histopathological correlation of malignant ependymomas with postoperative survival. J Neurosurg 1989;70:31-6.
112. Grant GA, Avellino AM, Loeser JD, et al. Management of intrinsic gliomas of the tectal plate in children: a ten-year review. Pediatr Neurosurg 1999;31:170-6.
113. Packer RJ, Nicholson HS, Vezina LG, et al. Brainstem gliomas. Neurosurg Clin N Am 1992;3:863-79.
114. Pollack IF, Pang D, Albright AL. The long-term outcome in children with late-onset aqueductal stenosis resulting from benign intrinsic tectal tumors. J Neurosurg 1994;80:681-8.
115. Squires LA, Allen JC, Abbott R, et al. Focal tectal tumors: management and prognosis. Neurology 1994;44:953-6.
116. Wellons JC, Tubbs RS, Banks JT, et al. Long-term control of hydrocephalus via endoscopic third ventriculostomy in children with tectal plate gliomas. Neurosurgery 2002;51(1):63-8.
117. Albright AL, Packer RJ, Zimmerman R, et al. Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group. Neurosurgery 1993;33:1026-30.
118. Fischbein N, Prados M, Wara W, et al. Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome. Pediatr Neurosurg 1996;24:9-23.
119. Sanford RA, Freeman CR, Burger P, et al. Prognostic criteria for experimental protocols in pediatric brainstem gliomas. Surg Neurol 1988;30:276-80.
120. Abbott R, Shiminski-Maher T, Wisoff JH, et al. Intrinsic tumors of the medulla: surgical complications. Pediatr Neurosurg 1992;17:239-44.
121. Edwards MSB, Wara WM, Ciricillo SF, et al. Focal brain-stem astrocytomas causing symptoms of involvement of the facial nerve nucleus: long-term survival in six pediatric patients. J Neurosurg 1994;80:20-5.
122. Robertson PL, Muraszko KM, Brunberg JA, et al. Pediatric midbrain tumors: a benign subgroup of brainstem gliomas. Pediatr Neurosurg 1995;22:65-73.
123. May PL, Blaser SI, Hoffman HJ, et al. Benign intrinsic tectal "tumors" in children. J Neurosurg 1991;74:867-71.
124. Epstein F, Constantini S. Practical decisions in the treatment of pediatric brain stem tumors. Pediatr Neurosurg 1996;24:24-34.
125. Packer RJ, Nicholson HS, Johnson DL, et al. Dilemmas in the management of childhood brain tumors: brainstem gliomas. Pediatr Neurosurg 1991;17:37-43.
126. Pierre-Kahn A, Hirsch J, Vinchon M, et al. Surgical management of brain-stem tumors in children: results and statistical analysis of 75 cases. J Neurosurg 1993;79:845-52.
127. Broniscer A, Leite CC, Lanchote VL, et al. Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem gliomas: results of a Brazilian cooperative study. Brainstem Glioma Cooperative Group. J Clin Oncol 2000;18(6):1246-53.
128. Jennings MT, Freeman ML, Murray MJ. Strategies in the treatment of diffuse pontine gliomas: the therapeutic role of hyperfractionated radiotherapy and chemotherapy. J Neurooncol 1996;28(2-3):207-22.
129. Wolff JE, Westphal S, Molenkamp G, et al. Treatment of paediatric pontine glioma with oral trophosphamide and etoposide. Br J Cancer 2002;87(9):945-9.
130. Kaplan AM, Albright AL, Zimmerman RA, et al. Brainstem gliomas in children: a Children's Cancer Group review of 119 cases. Pediatr Neurosurg 1996;24:185-92.
131. Farmer JP, Montes JL, Freeman CR, et al. Brainstem gliomas: a 10-year institutional review. Pediatr Neurosurg 2001;34(4):206-14.
132. Hoffman H, Yoshida M, Becker LE, et al. Pineal region tumors in childhood. Pediatr Neurosurg 1994;21:91-104.
133. Schild S, Scheithauer BW, Haddock MG, et al. Histologically confirmed pineal tumors and other germ cell tumors of the brain. Cancer 1996;78:2564-71.
134. Rubery ED, Wheeler TK. Metastases outside the central nervous system from a presumed pineal germinoma. J Neurosurg 1980;53:562-5.
135. Wilson ER, Takei Y, Bikhoff WT, et al. Abdominal metastases of primary intracranial yolk sac tumors through ventriculoperitoneal shunts. Report of three cases. Neurosurgery 1979;5:356-64.
136. Edwards M, Hudgins RJ, Wilson CB, et al. Pineal region tumors in children. J Neurosurg 1988;68:689-97.
137. Sakai N, Yamada H, Andoh T, et al. Long-term survival in malignant intracranial germ cell tumors. Child's Nerv Syst 1993;9:431-6.
138. Allen J, Kim JH, Packer RJ. Neoadjuvant chemotherapy for newly diagnosed germ-cell tumors of the central nervous system. J Neurosurg 1987;67:65-70.
139. Buckner J, Peethambaram PP, Smithson WA, et al. Phase II trial of primary chemotherapy followed by reduced dose radiation for CNS germ cell tumors. J Clin Oncol 1999;17:933-40.
140. Friedman JA, Lynch JJ, Buckner JC, et al. Management of malignant pineal germ cell tumors with residual mature teratoma. Neurosurgery 2001;48(3):518-22.
141. Kobayashi T, Yishida J, Ishiyama J, et al. Combination chemotherapy with cisplatin and etoposide for malignant intracranial germ-cell tumors. J Neurosurg 1987;70:676-81.
142. Patel S, Buckner JC, Smithson WA, et al. Cisplatin-based chemotherapy in primary central nervous system germ cell tumors. J Neurooncol 1992;12:47-52.
143. Ono N, Isobe I, Uki J, et al. Recurrence of primary intracranial germinomas after complete response with radiotherapy: recurrence patterns and therapy. Neurosurgery 1994;35:615-21.
144. Schild S, Haddock MG, Scheithauer BW, et al. Nongerminomatous germ cell tumors of the brain. Int J Radiat Oncol Biol Phys 1996;36:557-63.
145. Gilles FH, Sobel E, Leviton A, et al. Epidemiology of seizures in children with brain tumors: the Childhood Brain Tumor Consortium. J Neurooncol 1992;12(1):53-68.
146. Stiller CA, Nectoux J. International incidence of childhood brain and spinal tumors. Int J Epidemiol 1994;23(3):458-64.
147. Berger MS, Keles GE, Geyer JR. Cerebral hemispheric tumors of childhood. Pediatr Neuro-Oncol 1992;3:839-52.
148. Farwell JR, Dohrmann GJ, Flannery JT. Central nervous system tumors in children. Cancer 1977;40:3123-32.
149. Kleihues P, Cavenee WK, editors. World Health Organization classification of tumors: pathology and genetics: tumors of the nervous system. Lyon (France): IARC Press; 2000.
150. Giannini C, Sceithauer BW, Burger PC, et al. Pleomorphic xanthoastrocytoma: what do we really know about it? Cancer 1999;85:2033-45.
151. Celli P, Nofrone I, Palma L, et al. Cerebral oligodendroglioma: prognostic factors and life history. Neurosurgery 1994;35:1018-35.
152. Razack N, Baumgartner J, Bruner J. Pediatric oligodendrogliomas. Pediatr Neurosurg 1998; 28(3):121-9.
153. Shaw EG, Scheithauer BW, O'Fallon JR, et al. Oligodendrogliomas: the Mayo Clinic experience. J Neurosurg 1992;76:428-34.
154. Finlay JL, Wisoff JH. The impact of extent of resection in the management of malignant gliomas of childhood. Child's Nerv Syst 1999;15(11-12):786-8.
155. Wolff JE,Wagner S, Sindichakis M, et al. Simultaneous radiochemotherapy in pediatric patients with high-grade glioma: a phase I study. Anticancer Res 2002;22(6B):3569-72.
156. Schiffer D, Dutto A, Cavalla P, et al. Prognostic factors in oligodendroglioma. Can J Neurol Sci 1997;24:313-9.
157. Bowers DC, Mulne AF, Weprin B, et al. Prognostic factors in children and adolescents with low-grade oligodendrogliomas. Pediatr Neurosurg 2002;37(2):57-63.
158. Im SH, Chung CK, Cho BK, et al. Supratentorial ganglioglioma and epilepsy: postoperative seizure outcome. J Neurooncol 2002;57(1):59-66.
159. Hoyt WF, Baghdassarian SA. Optic glioma of childhood. Natural history and rationale for conservative management. Br J Ophthalmol 1969;53:793-8.
160. Rodriguez HA, Edwards MS, Levin VA. Management of hypothalamic gliomas in children: an analysis of 33 cases. Neurosurgery 1990;26:242-6.
161. Listernick R, Charrow J, Greenwald M, et al. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr 1994;125:63-6.
162. Ertem D, Acar Y, Alper G, et al. An uncommon and often overlooked cause of failure to thrive: diencephalic syndrome. J Pediatr Gastroenterol Nutr 2000;30(4):453-7.
163. Perilongo G, Carollo C, Salviati L, et al. Diencephalic syndrome and disseminated juvenile pilocytic astrocytomas of the hypothalamic-optic chiasm region. Cancer 1997;80(1):142-6.
164. Poussaint TY, Barnes PD, Nichols K, et al. Diencephalic syndrome: clinical features and imaging findings. AJNR Am J Neuroradiol 1997;18(8):1499-505.
165. Burger PC, Cohen KJ, Rosenblum MK, et al. Pathology of diencephalic astrocytomas. Pediatr Neurosurg 2000;32(4):214-9.
166. Silva MM, Goldman S, Keating G, et al. Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy. Pediatr Neurosurg 2000;33(3):151-8.
167. Allen JC. Initial management of children with hypothalamic and thalamic tumors and the modifying role of neurofibromatosis-1. Pediatr Neurosurg 2000;32(3):154-62.
168. DiMario FJ, Ramsby G, Greenstein R, et al. Neurofibromatosis type 1: magnetic resonance imaging findings. J Child Neurol 1993;8:32-9.
169. Farmer JP, Khan S, Khan A, et al. Neurofibromatosis type 1 and the pediatric neurosurgeon: a 20-year institutional review. Pediatr Neurosurg 2002;37(3):122-36.
170. Kornreich L, Blaser S, Schwarz M, et al. Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis. AJNR Am J Neuroradiol 2001;22(10):1963-9.
171. Steinbok P, Hentschel S, Almqvist P, et al. Management of optic chiasmatic/hypothalamic astrocytomas in children. Can J Neurol Sci 2002;29(2):132-8.
172. Tenny RT, Laws Jr ER, Younge BR, et al. The neurosurgical management of optic glioma: results in 104 patients. J Neurosurg 1982;57:452-8.
173. Wisoff JH, Abbott R, Epstein F. Surgical management of exophytic chiasmatic-hypothalamic tumors of childhood. J Neurosurg 1990;73:661-7.
174. Erkal HS, Serin M, Cakmak A. Management of optic pathway and chiasmatic-hypothalamic gliomas in children with radiation therapy. Radiother Oncol 1997;45(1):11-5.
175. Gold RJ, Hilal SK, Chutorian AM. Efficacy of radiotherapy in optic gliomas. Pediatr Neurol 1987;3:29-32.
176. Pierce SM, Barnes PD, Loeffler JS, et al. Definitive radiation therapy in the management of symptomatic patients with optic glioma: survival and long-term effects. Cancer 1990;65:45-52.
177. Rajakulasingam K, Cerullo LJ, Raimondi AJ. Childhood moyamoya syndrome: postradiation pathogenesis. Childs Brain 1979;5:467-75.
178. Servo A, Puranen M. Moyamoya syndrome as a complication of radiation therapy: case report. J Neurosurg 1978;48:1026-9.
179. Bakardjiev AI, Barnes PD, Goumnerova LC, et al. Magnetic resonance imaging changes after stereotactic radiation therapy for childhood low grade astrocytoma. Cancer 1996;76:864-74.
180. Packer RJ. Chemotherapy: low-grade gliomas of the hypothalamus and thalamus. Pediatr Neurosurg 2000;32(5):259-63.
181. Kato T, Sawamura Y, Tada M, et al. Cisplatin/vincristine chemotherapy for hypothalamic/visual pathway astrocytomas in young children. J Neurooncol 1998;37(3):263-70.
182. Delganis AV, Geyer JR, Berger MS. Prognostic significance of type 1 neurofibromatosis (von ecklinghausen disease) in childhood optic glioma. Neurosurgery 1996;38(6):1114-8.
183. Wiederholt WC, Gomez MR, Kurland LT. Incidence and prevalence of tuberous sclerosis in Rochester, Minnesota, 1950 through 1982. Neurology 1985;35:600-3.
184. Roach ES, Smith M, Huttenlocher P, et al. Diagnostic criteria - tuberous sclerosis. J Child Neurol 1992;7(2):221-4.
185. Braffman BH, Bilaniuk LT, Naidich TP, et al. MR imaging of tuberous sclerosis: pathogenesis of this phakomatosis, use of gadopentate dimeglumine, and literature review. Radiology 1992;183:227-38.
186. Shepherd CW, Gomez MR, Lie JT, et al. Causes of death in patients with tuberous sclerosis. Mayo Clin Proc 1991;66:792-6.
187. Halmagyi GM, Bignold LP, Alsop JL. Recurrent subependymal giant-cell astrocytoma in the absence of tuberous sclerosis. J Neurosurg 1979;50:106-9.
188. Kashiwagi N, Yoshihara W, Shimada N, et al. Solitary subependymal giant cell astrocytoma: case report. Eur J Radiol 2000;33(1):55-8.
189. Nishio S, Morioka T, Suzuki S, et al. Subependymal giant cell astrocytoma: clinical and neuroimaging features of four cases. J Clin Neurosci 2001;8(1):31-4.
190. Torres OA, Roach ES, Delgado MR, et al. Early diagnosis of subependymal giant cell astrocytoma in patients with tuberous sclerosis. J Child Neurol 1998;13(4):173-7.
191. Wiestler OD, Lopes BS, Green AJ, et al. Tuberous sclerosis complex and subependymal giant cell astrocytoma. In: Kleihues P, Cavenee WK, editors. World Health Organization classification of tumors: pathology and genetics: tumors of the nervous system. Lyon (France): IARC Press; 2000.
192. Medhkour A, Traul D, Husain M. Neonatal subependymal giant cell astrocytoma. Pediatr Neurosurg 2002;36(5):271-4.
193. Nabbout R, Santos M, Rolland Y, et al. Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis. J Neurol Neurosurg Psychiatry 1999;66(3):370-5.
194. Yamamoto K, Yamada K, Nakahara T, et al. Rapid regrowth of solitary subependymal giant cell astrocytoma-case report. Neurol Med Chir (Tokyo) 2002;42(5):224-7.
195. Ergun R, Okten AI, Yaman M, et al. Subependymal giant-cell astrocytoma associated with tuberous sclerosis: case-report. Neurosurg Rev 1998;21(2-3):185-8.
196. Beems T, Grotenhuis JA. Subependymal giant-cell astrocytoma in tuberous sclerosis: endoscopic images and implications for therapy. Minim Invasive Neurosurg 2001;44(1):58-60.
197. Roszkowski M, Drabik K, Braszez S, et al. Surgical treatment of intraventricular tumors associated with tuberous sclerosis. Child's Nerv Syst 1995;11(6):335-9.
198. Adamson TE, Wiestler OD, Kleihues P, et al. Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J Neurosurg 1990;73:12-7.
199. Sanford RA, Muhlbauer MS. Craniopharyngioma in children. Neurol Clin 1991;9(2):453-65.
200. Graziani N, Donnet A, Bugha T, et al. Ectopic basisphenoidal craniopharyngioma: case report and review of the literature. Neurosurgery 1994;34(2):346-9.
201. Kanungo N, Just N, Black M, et al. Nasopharyngeal craniopharyngioma in an unusual location. AJNR Am J Neuroradiol 1995;16:1372-4.
202. Zhang YQ, Wang CC, Ma ZY. Pediatric craniopharyngiomas: clinicomorphological study of 189 cases. Pediatr Neurosurg 2002;36(2):80-4.
203. Hoffman HJ, DeSilva M, Humphreys RP, et al. Aggressive surgical management of craniopharyngiomas in children. J Neurosurg 1992;76:47-52.
204. Rutka JT, Hoffman HJ, Drake JM, et al. Suprasellar and sellar tumors in childhood and adolescence. Neurosurg Clin N Am 1992;3(4):803-20.
205. Tomita T, McLone DG. Radical resections of childhood craniopharyngiomas. Pediatr Neurosurg 1993;19:6-14.
206. Sklar CA. Craniopharyngioma: endocrine abnormalities at presentation. Pediatr Neurosurg 1994;21(suppl 1):18-20.
207. Kalapurakal JA, Goldman S, Hsieh YC, et al. Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse. Med Pediatr Oncol 2003;40(4):214-8.
208. Merchant TE, Kiehna EN, Sanford RA, et al. Craniopharyngioma: the St. Jude Children's Research Hospital experience 1984- 2001. Int J Radiat Oncol Biol Phys 2002;53(3):533-42.
209. Van Effenterre R, Boch AL. Craniopharyngioma in adults and children: a study of 122 surgical cases. J Neurosurg 2002;97(1):3-11.
210. Schefter JK, Allen G, Cmelak AJ, et al. The utility of external beam radiation and intracystic 32P radiation in the treatment of craniopharyngiomas. J Neurooncol 2002;56(1):69-78.
211. Chiou SM, Lunsford LD, Niranjan A, et al. Stereotactic radiosurgery of residual or recurrent craniopharyngioma, after surgery, with or without radiation therapy. Neurooncol 2001;3(3):159-66.
212. Ulfarsson E, Lindquist C, Roberts M, et al. Gamma knife radiosurgery for craniopharyngiomas: long-term results in the first Swedish patients. J Neurosurg 2002;97(5 Suppl):613-22.
213. Mottolese C, Stan H, Hermier M, et al. Intracystic chemotherapy with bleomycin in the treatment of craniopharyngiomas. Child's Nerv Syst 2001;17(12):724-30.
214. Kim SK, Wang KC, Shin SH, et al. Radical excision of pediatric craniopharyngioma: recurrence pattern and prognostic factors. Child's Nerv Syst 2001;17(9):531-6.
215. Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, et al. Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures: report of thirty-nine cases. Neurosurgery 1988;23(5):545-56.
216. Degen R, Ebner A, Lahl R, et al. Various findings in surgically treated epilepsy patients with dysembryoplastic neuroepithelial tumors in comparison with those of patients with other low-grade brain tumors and other neuronal migration disorders. Epilepsia 2002;43(11):1379- 84.
217. Lee DY, Chung CK, Hwang YS, et al. Dysembryoplastic neuroepithelial tumor: radiological findings (including PET, SPECT, and MRS) and surgical strategy. J Neurooncol 2000;47(2):167-74.
218. Stanescu Cosson R, Varlet P, Beuvon F, et al. Dysembryoplastic neuroepithelial tumors: CT, MR findings and imaging follow-up: a study of 53 cases. J Neuroradiol 2001;28(4):230-40.
219. Fujisawa H, Marukawa K, Hasegawa M, et al. Genetic differences between neurocytoma and dysembryoplastic neuroepithelial tumor and oligodendroglial tumors. J Neurosurg 2002;97(6):1350-5.
220. Kameyama S, Fukuda M, Tomikawa M, et al. Surgical strategy and outcomes for epileptic patients with focal cortical dysplasia or dysembryoplastic neuroepithelial tumor. Epilepsia 2001;42(Suppl 6):37-41.
221. Hammond RR, Duggal N, Woulfe JM, et al. Malignant transformation of a dysembryoplastic neuroepithelial tumor: case report. J Neurosurg 2000;92(4):722-5.
222. Balestrini MR, Micheli R, Giordano L, et al. Brain tumors with symptomatic onset in the first two years of life. Child's Nerv Syst 1994;10:104-10.
223. Cohen BH, Packer RJ, Siegel KR, et al. Brain tumors in children under 2 years: treatment, survival and long-term prognosis. Pediatr Neurosurg 1993;19:171-9.
224. DiRocco C, Iannelli A, Ceddia A. Intracranial tumors of the first year of life: a cooperative study of the 1986- 1987 Education Committee of the ISPN. Child's Nerv Syst 1991;7:150-3.
225. Mapstone TB, Warf BC. Intracranial tumor in infants: characteristics, management, and outcome of a contemporary series. Neurosurgery 1991;28:343-8.
226. Gaffney CC, Sloane JP, Bradley NJ, et al. Primitive neuroectodermal tumors of the cerebrum: pathology and treatment. J Neurooncol 1985;3:23-33.
227. Asai A, Hoffman HJ, Hendrick EB, et al. Primary intracranial neoplasms in the first year of life. Child's Nerv Syst 1989;5:230-3.
228. Pascual-Castroviejo I, Villarejo F, Perez-Higueras A, et al. Childhood choroid plexus neoplasms: a study of 14 cases less than 2 years old. Eur J Pediatr 1983;140:51-6.